Company Filing History:

6 out of 4,770

Merck + Co., Inc.

patents

6 out of 1,323

G.d. Searle & Company

where one patent can have more than one assignee

Years Active: 1978-2003

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6552176 - Salt forms of 6-n-butylamino-6-deoxy-&agr;-L-sorbofuranose (2003-04-22),

2. 5916784 - Process for microbially oxidizing N-substituted glucamines (1999-06-29),

3. 5695969 - Process for producing N-substituted polyhydroxy nitrogen-containing (1997-12-09),

4. 5610039 - Process for producing N-substituted-1-deoxynojirimycin (1997-03-11),

5. 5602013 - Process for producing N-substituted-1-deoxynojirimycin (1997-02-11),

6. 5401645 - Process for producing n-substituted polyhydroxy nitrogen-containing (1995-03-28),

7. 4894444 - Recovery and purification of immunogens from immunogen-alum complexes (1990-01-16),

8. 4415670 - Motionless mixer as cell culture propagator (1983-11-15),

9. D261807 - Cell scraping device (1981-11-10),

10. 4296204 - Use of motionless mixer as cell culture propagator (1981-10-20),

11. 4264739 - Sparger for cell culture system (1981-04-28),

12. 4107072 - Process of isolating cyclohexane-free ethylcellulose microcapsules (1978-08-15),

Title: The Innovative Contributions of Roy W Grabner

Introduction

Roy W Grabner is a notable inventor based in Ballwin, MO (US). He has made significant contributions to the field of chemistry, particularly in the development of processes related to glucamines. With a total of 12 patents to his name, his work has had a considerable impact on various applications in the industry.

Latest Patents

Among his latest patents, Grabner has developed a process for producing salt forms of 6-n-butylamino-6-deoxy-α-L-sorbofuranose. This invention includes a method for oxidizing an N-substituted glucamine using an oxidizing microbe or extract, as well as a process for reducing the oxidized N-substituted glucamine to an N-substituted-1-deoxynojirimycin. Additionally, he has disclosed a one-pot process for producing N-substituted-1-deoxynojirimycin from D-glucose. Another significant patent involves the microbial oxidation of N-substituted glucamines, which shares similar processes and outcomes as his previous inventions.

Career Highlights

Throughout his career, Roy W Grabner has worked with prominent companies such as Merck & Company, Inc. and G.D. Searle & Company. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Grabner has collaborated with notable coworkers, including Bryan H Landis and Mike G Scaros. These partnerships have likely enhanced his innovative capabilities and led to the successful development of his patents.

Conclusion

Roy W Grabner's contributions to the field of chemistry and his innovative patents demonstrate his commitment to advancing scientific knowledge and applications. His work continues to influence the industry and inspire future inventors.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents (CIPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.